Business news – Page 9
-
OpinionTurning negative results into positives
Publishing unsuccessful experiments is more important than ever as we try to train machines in chemistry
-
BusinessTransforming sawdust with ultrasound
Bio-Sep can break down biomass and extract valuable molecules without damaging them
-
BusinessThousands of jobs to go as chemicals giants cut costs
Dow and 3M laying off a total of 4500 employees worldwide
-
BusinessContaminated cough syrups death toll passes 300 in four months
Deadly glycol contamination discovered in Uzbekistan, following cases in The Gambia and Indonesia
-
CareersMore guidance makes job and university applications fairer
A question-based format helps candidates prioritise what to tell recruiters
-
BusinessJ&J subsidiary claims key talc research is fraudulent
Complaint alleges study that helped link talc to cancer contained false information
-
BusinessEncoding creativity in drug discovery
Machine learning can complement and reinforce human intuition and experience
-
OpinionThe psychology of our future with AI
It’s time to accept that digitalisation is changing laboratory work, and embrace the opportunity
-
BusinessMerck & Co identifies nitrosamine source in diabetes drugs
Investigation uncovers the cause of contamination in sitagliptin medicines, but the wider nitrosamine problem is ballooning
-
WhitepaperSizing of temperature control units for reactor applications
When it comes to process chemistry, the right temperature is a crucial factor. In this whitepaper, we look at how the Unistat range of temperature control systems can impact the performance and quality in process chemical engineering.
-
NewsUS chemist Feng Tao avoids prison sentence for hiding ties to China
Judge’s ruling that professor did not harm his university or funding agency has crushed the government’s case
-
BusinessFatal explosion and fire at chemical plant in China
Five dead, a further eight missing, and 30 more injured at Panjin Haoye Chemical
-
BusinessExxonMobil scientists’ climate models were accurate, but hidden
Documents show internal predictions were as good as contemporary science but executives publicly downplayed their significance
-
BusinessSecond Alzheimer’s antibody approved in the US
Biogen–Eisai’s lecanemab can slow disease progression a little, but at significant cost and risk of side effects
-
OpinionSetting drug development speed records
The pandemic treatment sprint was spectacular, but hard to match under less unusual circumstances
-
Business3M pledges to exit PFAS manufacturing
Conglomerate will remove fluorochemicals from portfolio in a bid to stay ahead of rapidly tightening regulations
-
BusinessAnti-drift additives may volatilise alongside herbicides, causing pollution
Research suggests amine salts could be entering atmosphere, but manufacturers say lab model is unrealistic
-
BusinessUK antibiotics supply chain stretched by surge in Strep A infections
Government enacts protocols to enable substitute treatments and recommends preventive prescriptions in severe cases
-
BusinessChemicals industry roundup 2022
Russia’s invation of Ukraine mounted further pressure onto already strained supply chains
-
BusinessPharmaceuticals roundup 2022
Following the huge success of vaccines and treatments for covid-19, companies are upping their investment in R&D and dealmaking